MyAverix Finance
US · Healthcare
Cann Group Limited (CNGGF)
Drug Manufacturers - Specialty & Generic
Cann Group Limited (CNGGF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CNGGF
Cann Group Limited (CNGGF) — FAQ
What is CNGGF's P/E ratio?
The price-to-earnings (P/E) ratio for Cann Group Limited (CNGGF) is 18.00 (data as of 2026-03-24).
Does Cann Group Limited pay a dividend?
Dividend yield is not available in the current snapshot for Cann Group Limited (CNGGF). Check the MyAverix Finance app for the latest dividend data.
What sector is Cann Group Limited in?
Cann Group Limited (CNGGF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is CNGGF listed on?
CNGGF is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.